You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

October 7, 2020

Atthachai Homhuan Interviewed by Cannabis Law Report

On October 5, 2020, the Cannabis Law Report published an in-depth interview with Dr. Atthachai Homhuan, a manager in Tilleke & Gibbins’ regulatory affairs practice. The interview covers the development of Thailand’s regulatory environment for cannabis, how industry players can get involved, and Tilleke & Gibbins’ work with clients in the cannabis industry.

After giving an introduction to Tilleke & Gibbins and the firm’s work on behalf of clients in the cannabis industry, Dr. Atthachai discusses the background and current state of cannabis regulations in Thailand, and goes into the legal requirements surrounding medical cannabis, industrial hemp, and CBD-derived products. The interview then steers toward opportunities for foreign investment in Thai cannabis companies. Dr. Atthachai explains issues such as rules for cannabis companies operating in Thailand, import and export regulations, and the outlook for further foreign involvement in the Thai cannabis industry. Dr. Atthachai also demonstrates the firm’s regional capabilities by addressing the possibility of cannabis legalization in Laos and other neighboring countries.

To read the full interview, please visit the Cannabis Law Report  website.

RELATED INSIGHTS​ 

May 29, 2012
The ASEAN Economic Community (AEC), which will come into effect in 2015, will integrate the region’s economies and create a single market of 600 million consumers. All industries are bracing for this change, but the competitive landscape is transforming even more quickly in the healthcare sector. Regional harmonization has already commenced for the cosmetics industry, while further integration is imminent for other industries and products, such as medical devices.
May 29, 2012
The Thai pharmaceutical industry is characterized by its expanding yet challenging landscape. Amidst growing medical tourism and strong R&D centers in the Asia Pacific region, issues related to patent protection, counterfeit drugs, and innovation recognition are increasingly imperative for pharmaceutical companies.
April 26, 2012
Three members of the Tilleke & Gibbins team have been named to The International Who’s Who of Life Sciences Lawyers 2012. Published by Law Business Research, the official research partner of the International Bar Association, this guide identifies 546 experts in 48 jurisdictions who are considered leaders in serving clients in the life sciences sector.The Tilleke & Gibbins attorneys recognized by the publication are: